News One in Four Patients in Latest Clinical Study Show No Symptoms of Obstructive Sleep Apnea After Vivos Treatment
News Vivos Therapeutics Founder & Chief Medical Officer Releases New Book Highlighting His Groundbreaking Work
News Vivos Therapeutics Announces Closing of Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
News Vivos Therapeutics Announces Integrative Cardiologist Dr. Mimi Guarneri as New Medical Director of Clinical Education
News Vivos Therapeutics Forms Clinical Advisory Board to Drive Further Growth of Next-Generation Obstructive Sleep Apnea Treatment Efforts
News Vivos Therapeutics Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call for Thursday, March 25, 2021 at 5:00 pm ET
News Vivos Therapeutics to Participate in the Virtual 33rd Annual ROTH Conference on March 15-17, 2021
News Vivos Therapeutics Announces the Opening of the First Pneusomnia Integrated Medical-Dental Sleep Center
